Drugmakers Increasing Prices on More Than 500 Drugs in January
Data analyzed by health care research firm 3 Axis Advisors revealed that several pharmaceutical...
FDA Allows First-ever Canadian Drug Imports to the United States
On Jan. 5, 2023, the U.S. Food and Drug Administration (FDA) announced that it will allow Florida...
Understanding the Impact of Biosimilars on Employer Health Care Costs
Rising health care costs will likely continue to impact employers in the foreseeable future. The...
PBM Satisfaction Drops to 9-year Low
In 2023, customer satisfaction with pharmacy benefit managers (PBMs) reached its lowest level in...
The Industry Impact of Medicare Drug Price Negotiations
The Biden administration recently unveiled the first 10 prescription drugs subject to Medicare...
HHS Releases Revised Instructions for Upcoming Prescription Drug and Health Care Spending Reports
The Department of Health and Human Services (HHS) has released revised instructions for group...
House Committee Launches Probe Into PBMs
The U.S. House Oversight and Accountability Committee has launched an investigation into pharmacy...
HHS Secretary Responds to the President’s Executive Order on Drug Prices
On In response to President Joe Biden’s executive order on lowering prescription drug costs...
Feds Extend Prescription Drug Filing Deadline, Announce Relaxed Enforcement
The Departments of Labor, Health and Human Services, and the Treasury (collectively, the...
Submission Grace Period Issued for Prescription Drug Reporting
The transparency provisions of the No Surprises Act require group health plans and health...
December 27 Due Date for Prescription Drug Cost Reporting is Approaching
As part of the Consolidated Appropriations Act of 2021 (CAA), group health plans and carriers...
